4.3 Review

Aurora kinases: novel therapy targets in cancers

期刊

ONCOTARGET
卷 8, 期 14, 页码 23937-23954

出版社

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.14893

关键词

Aurora kinases; mitosis; cancer therapy target; Aurora kinases inhibitors; combination therapy

资金

  1. National Natural Science Foundation of China [81500120]
  2. Natural Science Foundation of Jiangsu Province [BK20150210]
  3. Jiangsu Shuangchuang Program and Jiangsu Distinguished Professorship Program

向作者/读者索取更多资源

Aurora kinases, a family of serine/threonine kinases, consisting of Aurora A (AURKA), Aurora B (AURKB) and Aurora C (AURKC), are essential kinases for cell division via regulating mitosis especially the process of chromosomal segregation. Besides regulating mitosis, Aurora kinases have been implicated in regulating meiosis. The deletion of Aurora kinases could lead to failure of cell division and impair the embryonic development. Overexpression or gene amplification of Aurora kinases has been clarified in a number of cancers. And a growing number of studies have demonstrated that inhibition of Aurora kinases could potentiate the effect of chemotherapies. For the past decades, a series of Aurora kinases inhibitors (AKIs) developed effectively repress the progression and growth of many cancers both in vivo and in vitro, suggesting that Aurora kinases could be a novel therapeutic target. In this review, we'll first briefly present the structure, localization and physiological functions of Aurora kinases in mitosis, then describe the oncogenic role of Aurora kinases in tumorigenesis, we shall finally discuss the outcomes of AKIs combination with conventional therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据